Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007:27:47-51.

Results of adjusted-dose heparin for thromboembolism prophylaxis in knee replacement compared to those found for its use in hip fracture surgery and elective hip replacement

David Yen  1 , William Weiss
Affiliations
Comparative Study

Results of adjusted-dose heparin for thromboembolism prophylaxis in knee replacement compared to those found for its use in hip fracture surgery and elective hip replacement

David Yen et al. Iowa Orthop J. 2007.

Abstract

The purpose of this study was to compare the results of adjusted-dose heparin (ADH) in the prevention of thromboembolism in knee replacement with those obtained for its use hip fracture surgery and elective hip replacement. Ultrasound was used to diagnose deep vein thrombosis (DVT) and ventilation/perfusion (V/Q) scan to diagnose pulmonary embolus (PE). Analysis of 438 operations was available. DVT was present after 9.7% of knee replacements, 7.2% of hip fracture operations and 6.8% of elective hip replacements. PE occurred in 1.2% of knee replacements, 0.9% of hip fracture operations and 2.5% of elective hip replacements. Proximal DVT occurred in 4.2% of knee replacements, 3.6% of hip fracture operations and 4.3% of elective hip replacements. Complications of heparin occurred in 4.6% of patients. Our ADH protocol was equally effective in prophylaxis against thromboembolism in knee replacement, hip fracture surgery and elective hip replacement. Direct comparison with other methods should not be done because ultrasound was used to screen for DVT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Average daily heparin
See this image and copyright information in PMC

References

    1. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3):338S–400S. - PubMed
    1. Agnelli G, Sonaglia F. Prevention of venous thromboembolism in high risk patients. Hematologica. 1997;82:496–502. - PubMed
    1. Freedman KB, Brookenthal KR, Fitzgerald RH, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg. 2000;82-A(7):929–939. - PubMed
    1. Muntz JE. Deep vein thrombosis and pulmonary embolism in the perioperative patient. American Journal of Managed Care. 2000;6(20):S1045–S1052. - PubMed
    1. Beisaw NE, Comerota AJ, Groth HE, Merli GJ, Weitz HH, Zimmerman RC, Diserio FJ, Sasahara AA. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. J Bone Joint Surg. 1988;70A:2–10. - PubMed

Publication types

MeSH terms

LinkOut - more resources